123 related articles for article (PubMed ID: 11850695)
21. Comparative palatability of 22 liquid antacids.
Temple ME; Nahata MC
Aliment Pharmacol Ther; 2000 Apr; 14(4):421-5. PubMed ID: 10759621
[TBL] [Abstract][Full Text] [Related]
22. Acid-neutralizing capacity and sodium content of antacid products from Belgium.
Gombatz VW
Clin Ther; 1984; 6(2):151-4. PubMed ID: 6705010
[TBL] [Abstract][Full Text] [Related]
23. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.
Vatier J; Célice-Pingaud C; Farinotti R
Fundam Clin Pharmacol; 1998; 12(6):573-83. PubMed ID: 9818289
[TBL] [Abstract][Full Text] [Related]
24. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
[TBL] [Abstract][Full Text] [Related]
25. Interaction of liquid aluminium phosphate and aluminium hydroxide with the gastric acid profile. Influence of food components and timing of meals.
Schürer-Maly CC; Varga L; Halter F
Scand J Gastroenterol; 1992 Apr; 27(4):263-9. PubMed ID: 1589702
[TBL] [Abstract][Full Text] [Related]
26. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
[TBL] [Abstract][Full Text] [Related]
27. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial.
McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C
Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434
[TBL] [Abstract][Full Text] [Related]
28. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.
Rohof WO; Bennink RJ; Smout AJ; Thomas E; Boeckxstaens GE
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1585-91; quiz e90. PubMed ID: 23669304
[TBL] [Abstract][Full Text] [Related]
29. A comparative crossover study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium--aluminium antacid gel.
Chevrel B
J Int Med Res; 1980; 8(4):300-2. PubMed ID: 6250928
[TBL] [Abstract][Full Text] [Related]
30. Heartburn requiring frequent antacid use may indicate significant illness.
Robinson M; Earnest D; Rodriguez-Stanley S; Greenwood-Van Meerveld B; Jaffe P; Silver MT; Kleoudis CS; Wilson LE; Murdock RH
Arch Intern Med; 1998 Nov; 158(21):2373-6. PubMed ID: 9827789
[TBL] [Abstract][Full Text] [Related]
31. The effects of famotidine, ranitidine and magnesium hydroxide/aluminium hydroxide on gastric fluid pH in adult horses.
Murray MJ; Grodinsky C
Equine Vet J Suppl; 1992 Feb; (11):52-5. PubMed ID: 9109961
[TBL] [Abstract][Full Text] [Related]
32. Effect of a new antacid on basal and meal-stimulated gastric secretion.
Sun DC; Rider JA
Am J Gastroenterol; 1978 Mar; 69(3 Pt 1):283-8. PubMed ID: 27093
[TBL] [Abstract][Full Text] [Related]
33. Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.
Sulz MC; Manz M; Grob P; Meier R; Drewe J; Beglinger C
Digestion; 2007; 75(2-3):69-73. PubMed ID: 17496418
[TBL] [Abstract][Full Text] [Related]
34. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis.
Saco LS; Orlando RC; Levinson SL; Bozymski EM; Jones JD; Frakes JT
Gastroenterology; 1982 Jun; 82(6):1369-73. PubMed ID: 7040158
[TBL] [Abstract][Full Text] [Related]
35. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of cimetidine and Mylanta II in the 6-week treatment of gastric ulcer.
Sherbaniuk RW; Wensel RH; Bailey RJ; Kirdeikis P; Fisher D; Thomson AB
J Clin Gastroenterol; 1985 Jun; 7(3):211-5. PubMed ID: 3894494
[TBL] [Abstract][Full Text] [Related]
40. Effect of an orally administered antacid agent containing aluminum hydroxide and magnesium hydroxide on abomasal luminal pH in clinically normal milk-fed calves.
Ahmed AE; Constable PD; Misk NA
J Am Vet Med Assoc; 2002 Jan; 220(1):74-9. PubMed ID: 12680452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
